AB Science SA (Euronext - FR0010557264 - AB) today provides an update on the Phase 1 study of the molecule AB8939 and the completion of Step 3, evaluating the combination of AB8939 + venetoclax in ...
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 2.3 MILLION PRIVATE PLACEMENT Paris, July 1st, 2026, 8am AB Science S.A. (the "Company" or "AB Science", Euronext - FR0010557264 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results